Harnessing RNA therapeutics: novel approaches and emerging strategies for cardiovascular disease management
RNA therapeutics are emerging as a promising approach for cardiovascular diseases (CVDs) management, offering targeted gene regulation through modalities like mRNA, siRNA, and miRNA. In recent years, researchers have conducted a lot of research on the application of RNA therapeutics technology in th...
Saved in:
| Main Authors: | Wang Dui, Zhao Xiaobin, Zhang Haifeng, Dang Lijuan, Huang Wenhui, Zhang Zhengfeng, Song Jinling |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1546515/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aptamer–ODN Chimeras: Enabling Cell-Specific ODN Targeting Therapy
by: Bei Xia, et al.
Published: (2025-05-01) -
Advanced Nanotechnology-Based Nucleic Acid Medicines
by: Noriko Miyamoto, et al.
Published: (2024-10-01) -
mRNA turnover rate limits siRNA and microRNA efficacy
by: Erik Larsson, et al.
Published: (2010-11-01) -
RNA interference and turnover in plants -a complex partnership
by: Michal Krzyszton, et al.
Published: (2025-07-01) -
Identification and analysis of miRNA - mRNA regulatory modules associated with resistance to bacterial leaf streak in rice
by: Baowei Wu, et al.
Published: (2025-03-01)